These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24421250)

  • 1. CALR mutation studies in chronic neutrophilic leukemia.
    Lasho TL; Elliott MA; Pardanani A; Tefferi A
    Am J Hematol; 2014 Apr; 89(4):450. PubMed ID: 24421250
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New mutations in myeloproliferative neoplasms; 2014 update].
    Kirito K
    Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
    Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
    Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
    [No Abstract]   [Full Text] [Related]  

  • 6. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Never judge a book by its cover: these neutrophils are not reactive!
    Rieu JB; Vergez F
    Blood; 2019 Aug; 134(7):656. PubMed ID: 31416815
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in allele frequencies of
    Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
    Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B; Chen X; Gao F; Li J; Wang HW
    Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
    [No Abstract]   [Full Text] [Related]  

  • 11. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T; Komatsu N; Kirito K
    Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.
    Carratt SA; Kong GL; Curtiss BM; Schonrock Z; Maloney L; Maniaci BN; Blaylock HZ; Baris A; Druker BJ; Braun TP; Maxson JE
    Blood; 2022 Aug; 140(6):644-658. PubMed ID: 35482940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF3R-, ASXL1-, and SETBP1-mutated chronic neutrophilic leukemia with monoclonal gammopathy of undetermined significance in a patient who developed severe ascites due to sinusoidal neutrophilic infiltration.
    Harada N; Mukai D; Izuta Y; Shibano I; Kizawa Y; Shiragami H; Ohnishi N; Hosaka N; Mugitani A
    Pathol Int; 2024 Feb; 74(2):93-95. PubMed ID: 38050833
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.
    Kawashima I; Kumagai T; Suzuki M; Suzuki J; Koshiishi M; Nakajima K; Kirito K
    Ann Hematol; 2019 Sep; 98(9):2249-2250. PubMed ID: 31240470
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders.
    Cross NCP; Godfrey AL; Cargo C; Garg M; Mead AJ;
    Br J Haematol; 2021 Nov; 195(3):338-351. PubMed ID: 34409596
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic Response of Chronic Neutrophilic Leukemia With CSF3R T618I, SETBP1, and ASXL1 Mutations After Decitabine Therapy.
    Cao S; Tao Q; Wang J; Zhang Q; Dong Y
    Am J Ther; 2024 Sep-Oct 01; 31(5):e550-e552. PubMed ID: 39292831
    [No Abstract]   [Full Text] [Related]  

  • 18. The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms.
    Holmström MO; Riley CH; Svane IM; Hasselbalch HC; Andersen MH
    Leukemia; 2016 Dec; 30(12):2413-2416. PubMed ID: 27560107
    [No Abstract]   [Full Text] [Related]  

  • 19. T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.
    Lee SE; Jo I; Jang W; Kim Y; Han K; Kim M
    Ann Lab Med; 2015 May; 35(3):376-8. PubMed ID: 25932451
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of myeloproliferative neoplasm-associated CALR mutations in acute promyelocytic leukemia.
    Langabeer SE; Haslam K
    Leuk Lymphoma; 2015 Apr; 56(4):1168-9. PubMed ID: 25115510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.